Metalidis C et al. |
Expression of CYP3A5 and P-glycoprotein in renal allografts with histological signs of calcineurin inhibitor nephrotoxicity. |
2011 |
Transplantation |
pmid:21544031
|
Ekberg H |
Calcineurin inhibitor sparing in renal transplantation. |
2008 |
Transplantation |
pmid:18813097
|
Gaynor JJ and Ciancio G |
The Importance of Using Serially Measured Tacrolimus Clearance Values, Especially During the Early Posttransplantation Period. |
2018 |
Transplantation |
pmid:29271869
|
Fischer L et al. |
Three-year Outcomes in De Novo Liver Transplant Patients Receiving Everolimus With Reduced Tacrolimus: Follow-Up Results From a Randomized, Multicenter Study. |
2015 |
Transplantation |
pmid:26151607
|
Satterthwaite R et al. |
Incidence of new-onset hypercholesterolemia in renal transplant patients treated with FK506 or cyclosporine. |
1998 |
Transplantation |
pmid:9484771
|
Takaya S et al. |
The adverse impact on liver transplantation of using positive cytotoxic crossmatch donors. |
1992 |
Transplantation |
pmid:1371195
|
Francavilla A et al. |
Inhibition of liver, kidney, and intestine regeneration by rapamycin. |
1992 |
Transplantation |
pmid:1371198
|
Rolles K et al. |
A pilot study of immunosuppressive monotherapy in liver transplantation: tacrolimus versus microemulsified cyclosporin. |
1999 |
Transplantation |
pmid:10551650
|
Nakamura Y et al. |
Acceptance of islet allografts in the liver of mice by blockade of an inducible costimulator. |
2003 |
Transplantation |
pmid:12717187
|
Qi S et al. |
Significant prolongation of renal allograft survival by delayed combination therapy of FK778 with tacrolimus in nonhuman primates. |
2003 |
Transplantation |
pmid:12717189
|
Calmus Y et al. |
Assessing renal function with daclizumab induction and delayed tacrolimus introduction in liver transplant recipients. |
2010 |
Transplantation |
pmid:20495510
|
Ouyang J et al. |
Effect of a novel inducible nitric oxide synthase inhibitor in prevention of rat chronic aortic rejections. |
2005 |
Transplantation |
pmid:15912108
|
Egli A et al. |
Inhibition of polyomavirus BK-specific T-Cell responses by immunosuppressive drugs. |
2009 |
Transplantation |
pmid:19935369
|
Boyer O et al. |
Improvement of renal function in pediatric heart transplant recipients treated with low-dose calcineurin inhibitor and mycophenolate mofetil. |
2005 |
Transplantation |
pmid:15912111
|
Selzner N et al. |
Antiviral treatment of recurrent hepatitis C after liver transplantation: predictors of response and long-term outcome. |
2009 |
Transplantation |
pmid:19935376
|
Abbott KC et al. |
New-onset gout after kidney transplantation: incidence, risk factors and implications. |
2005 |
Transplantation |
pmid:16340779
|
Villanueva G and Baldwin D |
Rosiglitazone therapy of posttransplant diabetes mellitus. |
2005 |
Transplantation |
pmid:16340782
|
Numakura K et al. |
Clinical and genetic risk factors for posttransplant diabetes mellitus in adult renal transplant recipients treated with tacrolimus. |
2005 |
Transplantation |
pmid:16340785
|
Koneru B et al. |
Blood transfusions in liver recipients: a conundrum or a clear benefit in the cyclosporine/tacrolimus era? |
1997 |
Transplantation |
pmid:9197350
|
Sugitani A et al. |
En bloc pancreas and kidney transplantation in a patient with limited vascular access. |
1997 |
Transplantation |
pmid:9197366
|
Shihab FS et al. |
Donor preconditioning with a calcineurin inhibitor improves outcome in rat syngeneic kidney transplantation. |
2009 |
Transplantation |
pmid:19202436
|
Metcalfe SM and Richards FM |
Cyclosporine, FK506, and rapamycin. Some effects on early activation events in serum-free, mitogen-stimulated mouse spleen cells. |
1990 |
Transplantation |
pmid:1691537
|
High KP |
The antimicrobial activities of cyclosporine, FK506, and rapamycin. |
1994 |
Transplantation |
pmid:7517076
|
Yoshimura N et al. |
The direct effect of FK506 and rapamycin on interleukin 1(beta) and immunoglobulin production in vitro. |
1994 |
Transplantation |
pmid:7517078
|
de Sandes-Freitas TV et al. |
Subclinical Lesions and Donor-Specific Antibodies in Kidney Transplant Recipients Receiving Tacrolimus-Based Immunosuppressive Regimen Followed by Early Conversion to Sirolimus. |
2015 |
Transplantation |
pmid:25929604
|
Hytiroglou P et al. |
FK506 versus cyclosporine as primary immunosuppressive agent for orthotopic liver allograft recipients. Histologic and immunopathologic observations. |
1993 |
Transplantation |
pmid:7506452
|
Ishizuka J et al. |
Effects of FK506 and cyclosporine on dynamic insulin secretion from isolated dog pancreatic islets. |
1993 |
Transplantation |
pmid:7506454
|
First MR |
Strategies to minimize immunological and nonimmunological risk factors in the renal transplant population. |
2001 |
Transplantation |
pmid:11585240
|
Sankary HN et al. |
FK506 treatment in combination with leflunomide in hamster-to-rat heart and liver xenograft transplantation. |
1998 |
Transplantation |
pmid:9798690
|
Murase N et al. |
FK506 suppression of heart and liver allograft rejection. II: The induction of graft acceptance in rats. |
1990 |
Transplantation |
pmid:1700504
|
Tarumi K et al. |
CTLA4IgG treatment induces long-term acceptance of rat small bowel allografts. |
1999 |
Transplantation |
pmid:10071020
|
Mack-Shipman LR et al. |
Reproductive hormones after pancreas transplantation. |
2000 |
Transplantation |
pmid:11063337
|
Pirsch JD et al. |
A comparison of tacrolimus (FK506) and cyclosporine for immunosuppression after cadaveric renal transplantation. FK506 Kidney Transplant Study Group. |
1997 |
Transplantation |
pmid:9112351
|
Jindal RM et al. |
Diabetogenicity of FK506 versus cyclosporine in liver transplant recipients. |
1994 |
Transplantation |
pmid:7519799
|
Mor E et al. |
Reversal of severe FK506 side effects by conversion to cyclosporine-based immunosuppression. |
1994 |
Transplantation |
pmid:7519800
|
Bellon H et al. |
The Effect of Immunosuppression on Airway Integrity. |
2017 |
Transplantation |
pmid:28471870
|
Erden E et al. |
Plasma FK506 levels in patients with histopathologically documented renal allograft rejection. |
1994 |
Transplantation |
pmid:7519801
|
Barten MJ et al. |
Synergistic effects of sirolimus with cyclosporine and tacrolimus: analysis of immunosuppression on lymphocyte proliferation and activation in rat whole blood. |
2004 |
Transplantation |
pmid:15114077
|
Uryuhara K et al. |
Thymectomy impairs but does not uniformly abrogate long-term acceptance of semi-identical liver allograft in inbred miniature Swine temporarily treated with FK506. |
2004 |
Transplantation |
pmid:15114080
|
Morikawa K et al. |
The distinct effects of FK506 on the activation, proliferation, and differentiation of human B lymphocytes. |
1992 |
Transplantation |
pmid:1281561
|
Baid-Agrawal S et al. |
Cardiovascular risk profile after conversion from cyclosporine A to tacrolimus in stable renal transplant recipients. |
2004 |
Transplantation |
pmid:15114085
|
Gruessner RW et al. |
Solitary pancreas transplantation for nonuremic patients with labile insulin-dependent diabetes mellitus. |
1997 |
Transplantation |
pmid:9415558
|
Lang T et al. |
Cholic acid synthesis is reduced in pediatric liver recipients during graft dysfunction due to ischemic injury and allograft rejection. |
1997 |
Transplantation |
pmid:9415561
|
Marino IR et al. |
Efficacy and safety of basiliximab with a tacrolimus-based regimen in liver transplant recipients. |
2004 |
Transplantation |
pmid:15385809
|
Couzi L et al. |
Immunological monitoring of calcineurin inhibitors for predicting cytomegalovirus infection in kidney transplant recipients. |
2008 |
Transplantation |
pmid:18946343
|
Horner BM et al. |
Recipient damage after musculocutaneous transplant rejection. |
2008 |
Transplantation |
pmid:18946349
|
di Francesco F et al. |
One year follow-up of steroid-free immunosuppression plus everolimus in isolated pancreas transplantation. |
2008 |
Transplantation |
pmid:18946356
|
Aulagnon F et al. |
Diarrhea after kidney transplantation: a new look at a frequent symptom. |
2014 |
Transplantation |
pmid:25073040
|
Abadja F et al. |
Impact of mycophenolic acid and tacrolimus on Th17-related immune response. |
2011 |
Transplantation |
pmid:21818055
|
Piao SG et al. |
Combined treatment of tacrolimus and everolimus increases oxidative stress by pharmacological interactions. |
2014 |
Transplantation |
pmid:24825522
|
Shimada T et al. |
Lowered blood concentration of tacrolimus and its recovery with changes in expression of CYP3A and P-glycoprotein after high-dose steroid therapy. |
2002 |
Transplantation |
pmid:12451243
|
Kaufman DB et al. |
The successful use of tacrolimus (FK506) in a pancreas/kidney transplant recipient with recurrent cyclosporine-associated hemolytic uremic syndrome. |
1995 |
Transplantation |
pmid:7541579
|
Herzog D et al. |
Normal glomerular filtration rate in long-term follow-up of children after orthotopic liver transplantation. |
2006 |
Transplantation |
pmid:16534467
|
Josephson MA et al. |
Treatment of renal allograft polyoma BK virus infection with leflunomide. |
2006 |
Transplantation |
pmid:16534472
|
Tanaka A et al. |
Living related liver transplantation across ABO blood groups. |
1994 |
Transplantation |
pmid:7522363
|
Devlin J et al. |
Nitric oxide generation. A predictive parameter of acute allograft rejection. |
1994 |
Transplantation |
pmid:7522365
|
McDiarmid SV et al. |
Factors affecting growth after pediatric liver transplantation. |
1999 |
Transplantation |
pmid:10030286
|
Shapiro R et al. |
A prospective, randomized trial of tacrolimus/prednisone versus tacrolimus/prednisone/mycophenolate mofetil in renal transplant recipients. |
1999 |
Transplantation |
pmid:10030287
|
Eckhoff DE et al. |
The safety and efficacy of a two-dose daclizumab (zenapax) induction therapy in liver transplant recipients. |
2000 |
Transplantation |
pmid:10830224
|
Krook H et al. |
Immunosuppressive drugs in islet xenotransplantation: a tool for gaining further insights in the mechanisms of the rejection process. |
2002 |
Transplantation |
pmid:12438951
|
Nakata Y et al. |
Tacrolimus and myocardial hypertrophy. |
2000 |
Transplantation |
pmid:10830241
|
Blaheta RA et al. |
Mycophenolate mofetil decreases endothelial prostaglandin E2 in response to allogeneic T cells or cytokines. |
2000 |
Transplantation |
pmid:10830246
|
Hanto DW and Chudzinski R |
What does the CONVERT trial really tell us about conversion from calcineurin inhibitors to sirolimus? |
2009 |
Transplantation |
pmid:19155968
|
Ericzon BG et al. |
Secretion and composition of bile after human liver transplantation: studies on the effects of cyclosporine and tacrolimus. |
1997 |
Transplantation |
pmid:9000664
|
Schena FP et al. |
Conversion from calcineurin inhibitors to sirolimus maintenance therapy in renal allograft recipients: 24-month efficacy and safety results from the CONVERT trial. |
2009 |
Transplantation |
pmid:19155978
|
Kelly PA et al. |
Ciprofloxacin does not block the antiproliferative effect of tacrolimus. |
1997 |
Transplantation |
pmid:9000686
|
Gouraud A et al. |
Follow-up of tacrolimus breastfed babies. |
2012 |
Transplantation |
pmid:22996303
|
Metcalfe S and Milner J |
Evidence that FK506 and rapamycin block T cell activation at different sites relative to early reversible phosphorylation involving the protein phosphatases PP1 and PP2A. |
1991 |
Transplantation |
pmid:1710844
|
Singh N et al. |
Infectious complications in liver transplant recipients on tacrolimus. Prospective analysis of 88 consecutive liver transplants. |
1994 |
Transplantation |
pmid:7524204
|
Langrehr JM et al. |
Evidence that indefinite survival of small bowel allografts achieved by a brief course of cyclosporine or FK506 is not due to systemic hyporesponsiveness. |
1992 |
Transplantation |
pmid:1384185
|
Pape E et al. |
Management of Tacrolimus-Telaprevir Drug-Drug Interaction in a Liver Transplant Patient With Hepatitis C Virus: Practical Considerations. |
2015 |
Transplantation |
pmid:26308424
|
McCarthy SA et al. |
The effects of immunosuppressive drugs on the regulation of activation-induced apoptotic cell death in thymocytes. |
1992 |
Transplantation |
pmid:1384186
|
MacDonald A |
Improving tolerability of immunosuppressive regimens. |
2001 |
Transplantation |
pmid:11833142
|
Dhar DK et al. |
The salutary effect of FK506 in ischemia-reperfusion injury of the canine liver. |
1992 |
Transplantation |
pmid:1384188
|
Bashuda H et al. |
Induction of persistent allograft tolerance in the rat by combined treatment with anti-leukocyte function-associated antigen-1 and anti-intercellular adhesion molecule-1 monoclonal antibodies, donor-specific transfusion, and FK506. |
1996 |
Transplantation |
pmid:8693525
|
Wang K et al. |
Transplantation of infantile bladder in rats: an alternative procedure for bladder augmentation. |
2001 |
Transplantation |
pmid:11213059
|
Nakajima K et al. |
Prolongation of cardiac xenograft survival in rats treated with 15-deoxyspergualin alone and in combination with FK506. |
1988 |
Transplantation |
pmid:2454521
|
Mollevà DG et al. |
Heart and liver xenotransplantation under low-dose tacrolimus: graft survival after withdrawal of immunosuppression. |
2001 |
Transplantation |
pmid:11213062
|
Kim SJ et al. |
A comparison of the effects of C2-cyclosporine and C0-tacrolimus on renal function and cardiovascular risk factors in kidney transplant recipients. |
2006 |
Transplantation |
pmid:17038908
|
Gruessner RW et al. |
Donor-specific portal blood transfusion in intestinal transplantation: a prospective, preclinical large animal study. |
1998 |
Transplantation |
pmid:9701258
|
Jain AB et al. |
Pregnancy after liver transplantation with tacrolimus immunosuppression: a single center's experience update at 13 years. |
2003 |
Transplantation |
pmid:14501862
|
Min SI et al. |
CYP3A5 *1 allele: impacts on early acute rejection and graft function in tacrolimus-based renal transplant recipients. |
2010 |
Transplantation |
pmid:21076384
|
Chan L et al. |
Multicenter, randomized study of the use of everolimus with tacrolimus after renal transplantation demonstrates its effectiveness. |
2008 |
Transplantation |
pmid:18360262
|
Hricik DE et al. |
Outcomes of African American kidney transplant recipients treated with sirolimus, tacrolimus, and corticosteroids. |
2002 |
Transplantation |
pmid:12151730
|
Saad ER et al. |
Successful treatment of BK viremia using reduction in immunosuppression without antiviral therapy. |
2008 |
Transplantation |
pmid:18360267
|
Ogawa H et al. |
Combination of tacrolimus, methotrexate, and methylprednisolone prevents acute but not chronic graft-versus-host disease in unrelated bone marrow transplantation. |
2002 |
Transplantation |
pmid:12151737
|
Murase N et al. |
Graft-versus-host disease after brown Norway-to-Lewis and Lewis-to-Brown Norway rat intestinal transplantation under FK506. |
1993 |
Transplantation |
pmid:7678353
|
Herold KC et al. |
Inhibition of glucose-stimulated insulin release from beta TC3 cells and rodent islets by an analog of FK506. |
1993 |
Transplantation |
pmid:7678356
|
Holman MJ et al. |
FK506-associated thrombotic thrombocytopenic purpura. |
1993 |
Transplantation |
pmid:7678357
|
Todo S et al. |
Small intestinal transplantation in humans with or without the colon. |
1994 |
Transplantation |
pmid:7512291
|
Griffith BP et al. |
A prospective randomized trial of FK506 versus cyclosporine after human pulmonary transplantation. |
1994 |
Transplantation |
pmid:7512292
|
Peduto G et al. |
Long-term host unresponsiveness to encapsulated xenogeneic myoblasts after transient immunosuppression. |
2000 |
Transplantation |
pmid:10919579
|
Sun S et al. |
Effect of tacrolimus on hemodynamics and absorption of experimental small intestinal transplants. |
1996 |
Transplantation |
pmid:8633368
|
Younes BS et al. |
The effect of immunosuppression on posttransplant lymphoproliferative disease in pediatric liver transplant patients. |
2000 |
Transplantation |
pmid:10919581
|
Gruber SA and Doshi MD |
Conversion to sirolimus in African American renal allograft recipients undergoing early steroid withdrawal: intermediate-term risks and benefits. |
2010 |
Transplantation |
pmid:20440195
|
Burger CI et al. |
Case report: drug interaction between tacrolimus and amiodarone with QT prolongation. |
2010 |
Transplantation |
pmid:20440199
|
Cherikh WS et al. |
A comparison of discharge immunosuppressive drug regimens in primary cadaveric kidney transplantation. |
2003 |
Transplantation |
pmid:12923430
|
Wong W et al. |
2005 immunosuppressive strategies in kidney transplantation: which role for the calcineurin inhibitors? |
2005 |
Transplantation |
pmid:16082321
|
Mendez R et al. |
A prospective, randomized trial of tacrolimus in combination with sirolimus or mycophenolate mofetil in kidney transplantation: results at 1 year. |
2005 |
Transplantation |
pmid:16082323
|
Oku M et al. |
Hepatocyte growth factor sustains T regulatory cells and prolongs the survival of kidney allografts in major histocompatibility complex-inbred CLAWN-miniature swine. |
2012 |
Transplantation |
pmid:22158517
|